ROI and Time-to-Market

Find Information Faster:

I'm in ... (choose one)
StudyWorks Login
Increase data accuracy while decreasing your trial size

Increase data accuracy while decreasing your trial size

ROI and Time-to-Market

The widespread adoption of eClinical Technologies includes the utilization of electronic diaries to maximize the advantages of an eClinical program. Electronic clinical trial technology reduces data variance requiring fewer patients. With eCOA, scientific outcomes are more conclusive, and greater power of study is achieved by reduced standard deviation.

The PHT eCOA integrated system is engineered to give you real-time insights into how patients feel and function, which ultimately helps you speed new therapies to market.

  • 5 Costs associated with paper that are eliminated by ePRO:


    1.  Data management time spent on trial cleanup after last patient out (LPO)

    2.  Queries on diary and/or questionnaire data

    3.  Double data entry when data must be transcribed from paper

    4.  Data management and extra sample sizing costs for missing and illogical data

    5.  Time required  to review handwritten diaries or perform complex calculations       

  • The Bottom Line

    The ultimate return on investment is an approved drug, treatment or therapy developed rapidly and ahead of the market.

    Learn about PHT Regulatory Expertise

  • Improving Trial Efficiencies

    Making the Business Case for ePRO

  • Time Travel is patented by PHT

    Time Travel (Clinical Investigation Data Logging With Contextual Time Shifting) is a unique feature of the PHT eCOA system. It allows authorized end users to automatically see how the eDiary works across the entire period of use, as opposed to manually calculating scheduled events.  Time travel also enables automated testing, for greater efficiencies.

    Watch the video

  • ePRO or Paper PRO?


    How and When to Justify Electronic Patient-Reported Outcomes (PRO)

PHT ePRO/eCOA solutions make collecting patient data faster and more accurate.

Darlene Panzitta
President & Founder
DSP Clinical, an award-winning CRO

Read More Testimonials